The ParaDNA® Screening Test is a part of the ParaDNA® Screening System. With minimal upfront training required, the ParaDNA® Screening System enables law enforcement and forensic practitioners to screen a small portion of their crime scene samples in order to obtain DNA-level information. The system provides the user with objective sample information estimating the quality and quantity of the DNA, as well as the gender of the sample’s contributor. The information generated can allow for better case prioritization, support decisions relating to an agency’s sample submission policy and enable more informed laboratory-processing decisions. The ParaDNA® Screening Test uses PCR technology to amplify and detect 3 human genetic markers (TH01, D16S539, and Amelogenin). The Screening Test determines if the remaining sample is likely to generate a useful genetic DNA profile in a laboratory workflow. The ParaDNA® Screening Test functions with the ParaDNA® Sample Collector
and ParaDNA® Screening Unit
. More Informed Evidence Prioritization and Processing Decisions
The ParaDNA® Screening System delivers results that can aid law enforcement and forensic practitioners to quickly determine which samples to submit or process for DNA analysis. The ParaDNA® system can help you better prioritize and focus your evidence submissions and DNA-processing decisions. Minimal Training Required for Use
The ParaDNA® Screening System supports direct or indirect sample collection from the forensic casework sample via the ParaDNA® Sample Collector. Once collected, the user simply applies the sample collector to the screening test plate and applies the test plate to the ParaDNA® Screening Unit. Following the 75-minute run time, the ParaDNA® Software (included with the screening unit) generates a simple relative percentage score that can be used to prioritize which samples are the most likely to contain the highest quality and quantities of human DNA. Targets Genetic Loci Commonly Used in Forensic Laboratory Analyses
The ParaDNA® Screening Test targets the STR loci TH01 and D16S539, as well as, the gender determining marker Amelogenin. All of these genetic loci are well characterized and used globally for forensic casework analysis. The test uses HyBeacon technology to detect common alleles for each of the included STR loci, as well as generates a call of the gender of the contributor of the DNA present in the sample.
The complete ParaDNA® Screening System was developed by LGC Forensics and is exclusively distributed by Life Technologies. For more information, visit http://paradna.lgcforensics.com.